FDA evaluates regulatory status of peptides amid rising public demand

The FDA is reviewing the safety and efficacy of various peptide compounds currently marketed for wellness, sleep, and anti-aging. The scrutiny follows increased public interest and promotion by high-profile figures, though the agency maintains that current evidence for these unregulated substances is insufficient.